Clinical Trial Update: Short-time Intervention in Post-Covid Syndrome Syndrome (SIPCOV): A Pragmatic Randomised Controlled Trial [NA]

View source ↗

Summary

The pragmatic randomized trial SIPCOV assessing a short-time intervention for post-COVID-19 syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: University Hospital, Akershus | Conditions: COVID-19 | NA | Status: COMPLETED